Validation of a novel single-cell RNA-sequencing method for biomedical research & human health
| Reference number | |
| Coordinator | Basic Genomics AB |
| Funding from Vinnova | SEK 317 000 |
| Project duration | November 2022 - November 2023 |
| Status | Completed |
| Venture | Innovative Startups |
| Call | Innovative Impact Startups autumn 2022 |
Important results from the project
During this project, Basic Genomics has developed BaseCode into a robust and reliable offering as a service. We have worked with early users to produce BaseCode datasets. These datasets have already started to provide novel insights into human disease and development and they will continue to do so as they are studied in more detail.
Expected long term effects
The support from Vinnova has helped us make substantial improvements to BaseCode technology and has allowed us to offer this groundbreaking technology to early users in Sweden and elsewhere in Europe. Early datasets are being analyzed and are already shedding light on human health and disease.
Approach and implementation
By implementing the BaseCode technology as a service we were able to quickly place our solution in customers´ hands and confirm their interest as well as the performance of our technology. This allowed us to achieve the most important goal of the project and based on both customer feedback and our own QC metrics we have confirmed the method is performing well and is outperforming competitors´ technologies.